Pirfenex
Pirfenex

0.72
A generic medicine indicated for pain and inflammation. Reduces tissue scarring and eases inflammation by blocking proteins that drive fibrotic activity.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Pirfenidone
Reference Brand
Pirfenidone
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Antifibrotic Agent
Pharmacological Class
Pyridone Antifibrotic
Clinical Indications
Manufacturer Description
Utilized to manage fibrotic tissue buildup to alleviate lung scarring and support pulmonary capacity.
Mechanism of Action
Suppresses synthesis of transforming growth factor-beta and tumor necrosis factor-alpha, stopping collagen accumulation inside tissues.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
12 hours
Contraindications
Severe hepatic impairment, Severe renal impairment requiring dialysis, Concurrent fluvoxamine use
Severe Adverse Events
Severe drug-induced hepatotoxicity — requires immediate medical attention, Angioedema — requires immediate medical attention
Common Side Effects
Nausea, Vomiting, Photosensitivity
Uncommon Side Effects
Skin rash, Fatigue, Dyspepsia
Drug Interactions
Fluvoxamine, Ciprofloxacin, Tobacco
Pregnancy Safety Warnings
TGA Category C: Limited clinical records. Avoid in pregnancy. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Information related to Pirfenex is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Hepatitis Treatment AU - Buy Entecavir AU